The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian and international blood cancer researchers
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Over $53 million has been committed to blood cancer research since 2010.
67 research projects funded enabling over 98 research positions.
Over 6,200 genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled 1,817 patients to participate in clinical trials supported by Snowdome.
Latest News
From Diagnosis to Advocacy: Tahli’s Journey with life-changing CAR T-cell Therapy
Tahli’s life took an unexpected turn in the autumn of 2020. A busy mother of two and a talented baker, she found herself facing a daunting diagnosis: stage 4 lymphoma. As she navigated her journey from diagnosis to treatment and ultimately remission, Tahli’s story became one of hope and advocacy for groundbreaking medical treatments like … Continued
Read moreInterview with Helen Buckingham OAM
We recently sat down with Snowdome Board Director, Helen Buckingham OAM, to get her thoughts on the funding of a new immunotherapy treatment for myeloma, and how clinicians and patients can have their say.
Read moreVital boost to blood cancer treatment
A state of the art, purpose-built laboratory complex in Victoria will provide new hope to Australian blood cancer patients.
Read more